caitlin madevu-matson ([email protected]) charon gwynn ([email protected]) si-ny
DESCRIPTION
Insights into HIV Care Service Comprehensiveness and Laboratory Capacity at ICAP-supported Facilities: Findings from PFaCTS 2013. Caitlin Madevu-Matson ([email protected]) Charon Gwynn ([email protected]) SI-NY. PFaCTS. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/1.jpg)
INSIGHTS INTO HIV CARE SERVICE
COMPREHENSIVENESS AND
LABORATORY CAPACITY AT ICAP-SUPPORTED FACILITIES:
FINDINGS FROM PFACTS 2013Caitlin Madevu-Matson ([email protected])
Charon Gwynn ([email protected])SI-NY
![Page 2: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/2.jpg)
PFACTS• Structured repeated assessment of facilities to
describe the scope, diversity, capacity and comprehensiveness of ICAP-supported programs
• Captures information not available from routine indicators :– Context: Location, type– Facility characteristics: Related services, e.g.
ANC, MC– Clinic and lab components: Staffing configuration
and training, patient support services, laboratory quality essentials
• Data used for program planning, monitoring and evaluation– Reports and webinars– URS– Analyses with other data sources
![Page 3: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/3.jpg)
PFACTS IMPLEMENTATION
• Assessment tools– Core questions maintained from previous
round, tool revised with clinical and programs units
• Data collection– Assessments completed with health facility
personnel– Questionnaires reviewed by in-country ICAP
clinical and M&E units• Data validated through checks and results
uploaded to URS
Care and Treatment PFaCTS
• 7 rounds, 2007 - 2013
• 80 questions
Laboratory PFaCTS• 2 rounds, 2011 -
2013• 162 questions
![Page 4: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/4.jpg)
CARE & TREATMENT PFACTS
Objectives• Present results
from Care and treatment PFaCTS Round 7
• Describe the comprehensiveness of ICAP-supported programs
![Page 5: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/5.jpg)
OUTLINE
• PFaCTS implementation
• Current characteristics– Context
– Facility
– Clinic
• Comprehensiveness of HIV Care Service
• Summary
• Implications
![Page 6: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/6.jpg)
DEFINITIONS
Facility
Clinic
![Page 7: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/7.jpg)
COMPLETENESS OF PFACTS REPORTING OVER TIME
Round 1 (2007)
Round 2 (2007)
Round 3 (2008)
Round 4 (2009)
Round 5 (2010)
Round 6 (2011)
Round 7 (2013)
-
200
400
600
800
1,000
1,200
211 227
356
541
687
1,003 1,062
158 202
345
490
665
977 1,017
Facilities supported Facilities assessed
Num
ber o
f fac
ilitie
s
![Page 8: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/8.jpg)
COMPLETENESS OF PFACTS REPORTING OVER TIME
Round 1 (2007)
Round 2 (2007)
Round 3 (2008)
Round 4 (2009)
Round 5 (2010)
Round 6 (2011)
Round 7 (2013)
-
200
400
600
800
1,000
1,200
211 227
356
541
687
1,003 1,062
158 202
345
490
665
977 1,017
Facilities supported Facilities assessed
Num
ber o
f fac
ilitie
s
75%
96%
![Page 9: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/9.jpg)
OUTLINE
• PFaCTS implementation
• Current characteristics– Context : country, location and type
– Facility : services provided outside the CT clinic
– Clinic : services provided in the CT clinic
• Comprehensiveness of HIV Care Service
• Summary
• Implications
![Page 10: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/10.jpg)
COUNTRIES CONTRIBUTING TO PFACTS ROUND 7
• 96% (1017/1062) of facilities with ICAP-supported care and treatment services completed PFaCTS Round 7
• In country completeness ranged from 79% to 100%
Cote d'Ivoire n=27 DR Congo
n=50
Ethiopia n=312
Kenya n=260
Mozambique
n=77
Swaziland
n=83
Tanzania
n=208
![Page 11: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/11.jpg)
FACILITY LOCATION AND TYPE
Geographic location Type of facility0
20
40
60
80
100
Urban; 16.71583088
Semi-urban; 32.74336283
Rural; 50.54080629
Public primary; 64
Public secondary / ter-tiary; 15
Private/other; 21
Perc
ent o
f fac
ilitie
s, %
![Page 12: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/12.jpg)
AVAILABILITY OF HIV RELATED SERVICES (n=1017)
PITC in any clinic/ward PMTCT in ANC TB treatment0
20
40
60
80
100100 97
88
Perc
ent o
f fac
ilitie
s, %
![Page 13: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/13.jpg)
PMTCT SERVICE VARIATION (N=991)
ART in ANC WHO Option0
20
40
60
80
100
ART in ANC; 64.48
Refer to HIV clinic; 32.8
Refer to other facility, 2.72
Option A; 66
Option B; 3
Option B+; 30
Perc
ent o
f fac
ilitie
s, %
![Page 14: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/14.jpg)
TB SERVICE VARIATION (N=1,017)
IPT Triage of TB suspects TB treatment0
20
40
60
80
100
58.672
TB clinic only; 60.18
HIV care clinic only; 20.94
HIV care and TB clinic; 6.59
Perc
ent o
f fac
ilitie
s, %
![Page 15: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/15.jpg)
AVAILABILITY OF KEY PATIENT SUPPORT SERVICES (n=1017)
ART adherenc
e coun
seling
Male condo
m provision
Outreach
Nutritiona
l treatm
ent (children
)
Nutritio
nal tr
eatment
(adults)
0
20
40
60
80
100 99
8881 79
74
Perc
ent o
f fac
ilitie
s, %
![Page 16: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/16.jpg)
TYPE OF ART ADHERENCE SUPPORT AVAILABLE
Clinic a
ppoin
tmen
t remind
er ca
rds
Hando
uts
Pill box
es or
bliste
r pac
ks
Calend
ars or
chec
klist to
track
ART
Clinic s
creen
s edu
catio
nal vi
deos
0
20
40
60
80
100
82
28 24
5 3
Perc
ent o
f fac
ilitie
s, %
![Page 17: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/17.jpg)
OUTREACH ACTIVITIES BY TYPE OF PERSONNEL
Peer educator Clinicians Outreach worker Social worker Other0
20
40
60
80
100
61
42
16
59
Perc
ent o
f fac
ilitie
s, %
![Page 18: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/18.jpg)
SECONDARY PREVENTION SERVICE AVAILABILITY
0
20
40
60
80
100 99
7870
45
Perc
ent o
f fac
ilitie
s, %
![Page 19: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/19.jpg)
OUTLINE
• PFaCTS implementation
• Current characteristics– Context
– Facility
– Clinic
• Comprehensiveness of HIV Care Service
• Summary
• Implications
![Page 20: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/20.jpg)
HIV CARECOMPREHENSIVENE
SSCOMPONENTSQuestions
• Does ICAP support comprehensive HIV care programs?
• Has comprehensiveness of HIV care programs changed over time?
• Is there variability in the changes?
![Page 21: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/21.jpg)
WHO Priority Interventions1. Enabling people to know their HIV status
VCT / PITC
2. Maximizing the health sector’s response to HIV preventionPreventing sexual transmissionInterventions for IDU
PMTCT
3. Scaling up HIV/AIDS treatment and care
Preventing and treating illness
Treatment and care for HIV
Lab services for HIV monitoring
![Page 22: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/22.jpg)
WHO Priority Interventions
Comprehensive components from PFaCTS
1. Enabling people to know their HIV status
VCT / PITC PITC on-site
2. Maximizing the health sector’s response to HIV preventionPreventing sexual transmission
Education on behavior change, STI screening, condoms
Interventions for IDU Screening and education on substance use
PMTCT PMTCT on-site
3. Scaling up HIV/AIDS treatment and care
Preventing and treating illness
Cotrimoxazole and TBNutritional counseling
Treatment and care for HIV
Adherence support Outreach services
Lab services for HIV monitoring CD4 on- or off-site
![Page 23: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/23.jpg)
WHO Priority Interventions
Comprehensive components from PFaCTS
1. Enabling people to know their HIV status
VCT / PITC PITC on-site
2. Maximizing the health sector’s response to HIV preventionPreventing sexual transmission
Education on behavior change, STI screening, condoms
Interventions for IDU Screening and education on substance use
PMTCT PMTCT on-site
3. Scaling up HIV/AIDS treatment and care
Preventing and treating illness
Cotrimoxazole and TBNutritional counseling
Treatment and care for HIV
Adherence support Outreach services
Lab services for HIV monitoring CD4 on- or off-site
![Page 24: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/24.jpg)
WHO Priority Interventions
Comprehensive components from PFaCTS
1. Enabling people to know their HIV status
VCT / PITC PITC on-site
2. Maximizing the health sector’s response to HIV preventionPreventing sexual transmission
Education on behavior change, STI screening, condoms
Interventions for IDU Screening and education on substance use
PMTCT PMTCT on-site
3. Scaling up HIV/AIDS treatment and care
Preventing and treating illness
Cotrimoxazole and TBNutritional counseling
Treatment and care for HIV
Adherence support Outreach services
Lab services for HIV monitoring CD4 on- or off-site
![Page 25: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/25.jpg)
WHO Priority Interventions
Comprehensive components from PFaCTS
1. Enabling people to know their HIV status
VCT / PITC PITC on-site
2. Maximizing the health sector’s response to HIV preventionPreventing sexual transmission
Education on behavior change, STI screening, condoms
Interventions for IDU Screening and education on substance use
PMTCT PMTCT on-site
3. Scaling up HIV/AIDS treatment and care
Preventing and treating illness
Cotrimoxazole and TBNutritional counseling
Treatment and care for HIV
Adherence support Outreach services
Lab services for HIV monitoring CD4 on- or off-site
![Page 26: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/26.jpg)
WHO Priority Interventions
Comprehensive components from PFaCTS
1. Enabling people to know their HIV status
VCT / PITC PITC on-site
2. Maximizing the health sector’s response to HIV preventionPreventing sexual transmission
Education on behavior change, STI screening, condoms
Interventions for IDU Screening and education on substance use
PMTCT PMTCT on-site
3. Scaling up HIV/AIDS treatment and care
Preventing and treating illness
Cotrimoxazole and TBNutritional counseling
Treatment and care for HIV
Adherence support Outreach services
Lab services for HIV monitoring CD4 on- or off-site
![Page 27: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/27.jpg)
WHO Priority Interventions
Comprehensive components from PFaCTS
1. Enabling people to know their HIV status
VCT / PITC PITC on-site
2. Maximizing the health sector’s response to HIV preventionPreventing sexual transmission
Education on behavior change, STI screening, condoms
Interventions for IDU Screening and education on substance use
PMTCT PMTCT on-site
3. Scaling up HIV/AIDS treatment and care
Preventing and treating illness
Cotrimoxazole and TBNutritional counseling
Treatment and care for HIV
Adherence support Outreach services
Lab services for HIV monitoring CD4 on- or off-site
![Page 28: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/28.jpg)
WHO Priority Interventions
Comprehensive components from PFaCTS
1. Enabling people to know their HIV status
VCT / PITC PITC on-site
2. Maximizing the health sector’s response to HIV preventionPreventing sexual transmission
Education on behavior change, STI screening, condoms
Interventions for IDU Screening and education on substance use
PMTCT PMTCT on-site
3. Scaling up HIV/AIDS treatment and care
Preventing and treating illness
Cotrimoxazole and TBNutritional counseling
Treatment and care for HIV
Adherence support Outreach services
Lab services for HIV monitoring CD4 on- or off-site
![Page 29: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/29.jpg)
WHO Priority Interventions
Comprehensive components from PFaCTS
1. Enabling people to know their HIV status
VCT / PITC PITC on-site
2. Maximizing the health sector’s response to HIV preventionPreventing sexual transmission
Education on behavior change, STI screening, condoms
Interventions for IDU Screening and education on substance use
PMTCT PMTCT on-site
3. Scaling up HIV/AIDS treatment and care
Preventing and treating illness
Cotrimoxazole and TBNutritional counseling
Treatment and care for HIV
Adherence support Outreach services
Lab services for HIV monitoring CD4 on- or off-site
![Page 30: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/30.jpg)
WHO Priority Interventions
Comprehensive components from PFaCTS
1. Enabling people to know their HIV status
VCT / PITC PITC on-site
2. Maximizing the health sector’s response to HIV preventionPreventing sexual transmission
Education on behavior change, STI screening, condoms
Interventions for IDU Screening and education on substance use
PMTCT PMTCT on-site
3. Scaling up HIV/AIDS treatment and care
Preventing and treating illness
Cotrimoxazole and TBNutritional counseling
Treatment and care for HIV
Adherence support Outreach services
Lab services for HIV monitoring CD4 on- or off-site
![Page 31: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/31.jpg)
WHO Priority Interventions
Comprehensive components from PFaCTS
1. Enabling people to know their HIV status
VCT / PITC PITC on-site
2. Maximizing the health sector’s response to HIV preventionPreventing sexual transmission
Education on behavior change, STI screening, condoms
Interventions for IDU Screening and education on substance use
PMTCT PMTCT on-site
3. Scaling up HIV/AIDS treatment and care
Preventing and treating illness
Cotrimoxazole and TBNutritional counseling
Treatment and care for HIV
Adherence support Outreach services
Lab services for HIV monitoring CD4 on- or off-site
![Page 32: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/32.jpg)
WHO Priority Interventions
Comprehensive components from PFaCTS
1. Enabling people to know their HIV status
VCT / PITC PITC on-site
2. Maximizing the health sector’s response to HIV preventionPreventing sexual transmission
Education on behavior change, STI screening, condoms
Interventions for IDU Screening and education on substance use
PMTCT PMTCT on-site
3. Scaling up HIV/AIDS treatment and care
Preventing and treating illness
Cotrimoxazole and TBNutritional counseling
Treatment and care for HIV
Adherence support Outreach services
Lab services for HIV monitoring CD4 on- or off-site
![Page 33: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/33.jpg)
COMPREHENSIVE SERVICES OVER TIME
2007 n= 245
2008 n= 345
2009 n= 490
2009 n= 666
2011 n= 977
2013 n= 1017
0
20
40
60
80
100
1624
5569 73 73
5344
29
23 18 2230 26
148 9 41 5 2 1
High (7) Medium (6) Low (3-5) Very low (<3)
Perc
ent o
f fac
ilitie
s, %
![Page 34: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/34.jpg)
COMPREHENSIVE SERVICES OVER TIME, SUBSET
2007 2008 2009 2010 2011 20130
20
40
60
80
100
16
24
55
6973 73
1518
57
94 92 90
All participating facilities (increasing n) Subset of facilities participating in every round (n=93)
Perc
ent o
f fac
ilitie
s, %
![Page 35: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/35.jpg)
COMPREHENSIVE SERVICES OVER TIME, BY FACILITY TYPE
Public Primary Public Secondary/Tertiary Private/Other0
20
40
60
80
100
2007 2008 2009 2010 2011 2013
Perc
ent o
f fac
ilitie
s, %
![Page 36: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/36.jpg)
OUTLINE
• PFaCTS implementation
• Current characteristics– Context
– Facility
– Clinic
• Comprehensiveness of HIV Care Service
• Summary
• Implications
![Page 37: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/37.jpg)
CT SUMMARY (1)
• Overall, ICAP facilities maintained high survey completeness
• High on-site availability of essential HIV care services• Counseling and testing• PMTCT• TB treatment• ART adherence counseling• Outreach • Nutritional counseling• Secondary prevention
![Page 38: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/38.jpg)
CT SUMMARY (2)
• The comprehensiveness of essential HIV care services at all ICAP-supported facilities increased rapidly in 2009 and seems to have stabilized
• Higher proportion of facilities have comprehensive services in • Facilities supported by ICAP for longer time• Public primary and secondary/tertiary
compared to private/other
![Page 39: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/39.jpg)
• ICAP-supported facilities provide comprehensive services even though most facilities are rural and public primary facilities
• Scale up and expansion of ICAP support to new areas may mean not all facilities will be equipped to offer comprehensive services
• Combine PFaCTS results with routinely collected program and clinical data
– Confirm if availability of comprehensive services is beneficial for program and patient outcomes
– Advocate for wider implementation of comprehensive service delivery models
IMPLICATIONS FOR HIV CARE AND TREATMENT
![Page 40: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/40.jpg)
Laboratory PFaCTS
![Page 41: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/41.jpg)
Outline• Rationale & Objectives• General findings• Capacity score• Summary& Implications
![Page 42: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/42.jpg)
Laboratory PFaCTS• Captures information on the scope, diversity,
and capacity of ICAP-supported laboratories• Provides information on laboratory quality
essentials (QEs)– Infrastructure and equipment– Human resources– Quality assurance activities– Facility safety– Supply chain management
• Two rounds of PFaCTS conducted to date (2011 & 2013)
![Page 43: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/43.jpg)
RATIONALE FOR LABORATORY PFACTS
• At the facility level:– Measure capacity and progress toward
accreditation– Gap analysis and development of laboratory
specific improvement plan
• At the program level:– Identify gaps in implementing QEs across
supported labs– Prioritization and strategy development
![Page 44: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/44.jpg)
ICAP’S LABORATORY CAPACITY BUILDING FRAMEWORK
Objective Components
1. Improve Integrated Laboratory Infrastructure
physical infrastructure, equipment and accessories
2. Strengthen laboratory personnel capacity
personnel capacity to provide high-quality diagnostic services
3. Improve Laboratory Quality Management System
quality management systems & lab accreditation
4. Strengthen the laboratory network system
laboratory referral system & EQA schemes
![Page 45: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/45.jpg)
OBJECTIVES• To summarize findings from Lab
PFaCTS 2013
• To compare laboratory capacity between years and by key characteristics
![Page 46: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/46.jpg)
OUTLINE• Rationale & Objectives• General findings• Capacity score• Summary& Implications
![Page 47: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/47.jpg)
PEPFAR DEFINITION OF CLINICAL LABORATORY
Laboratory that has the capacity to: Perform testing for the diagnosis of HIV infection with either rapid test, EIA or molecular methods; and
Has dedicated laboratory personnel
Perform clinical laboratory tests in any of the following areas:Hematology - Clinical chemistry - Serology Microbiology - CD4 testing - HIV viral loads
TB diagnostic - Malaria diagnosis - OI diagnosis
![Page 48: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/48.jpg)
LABORATORIES COMPLETING PFACTS 2013
# Supported # Reported % Reported
Ethiopia 295 289 98
Kenya 184 182 99
Tanzania 175 119 68
Mozambique 58 53 91
Cote d'lvoire 10 4 40
DR Congo 8 7 88
All Countries 730 654 90
![Page 49: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/49.jpg)
ICAP SUPPORTED LABORATORIES BY FACILITY TYPE AND COUNTRY
All countries (n=654)
Kenya (n=182)
Tanzania (n=119)
Ethiopia (n=289)
Mozambique (n=53)
Cote d'Ivoire (n=4)
DR Congo (n=7)
0
20
40
60
80
100
7887
6680 77
14
1913
26
18 21
10086
3 1 8 2 2
Primary Secondary Tertiary/reference lab
Perc
ent o
f lab
orat
orie
s, %
![Page 50: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/50.jpg)
TYPE OF SUPPORT PROVIDED BY ICAP
AccreditationConstruction/revnovation
RefurbishmentSafety supplies
Processing suppliesEquipment maintenance
Human resourcesTest kit/regent supply
EQASample transportation
EquipmentSupervision
Documents developmentTraining & mentoring
0 20 40 60 80 100
9
15
18
22
25
33
36
41
53
62
69
69
80
91
Percent of laboratories, %
![Page 51: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/51.jpg)
TYPE OF HIV-RELATED TESTS PERFORMED ONSITE
HIV rapid test AFB Syphilis Hematology CD4 count Clinic chem-istry
CD4 percent0
20
40
60
80
10097
9283
48
27 26
9
Perc
ent o
f lab
orat
orie
s, %
![Page 52: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/52.jpg)
Light/F
luoresce
nce m
icrosc
ope
Refrigerator
Back up g
enerator
Hemotolog
y analy
zer
Clinical ch
emistry a
nalyze
r
CD4 mac
hine 0
20
40
60
80
100
88
69
42
28 25 22
ESSENTIAL EQUIPMENT FOR HIV CARE
Perc
ent o
f lab
orat
orie
s, %
![Page 53: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/53.jpg)
TYPE OF BIOSAFETY EQUIPMENT
Lab coat Detergents Sharps container
Hand wash sta-
tion
Fire ex-tinguisher
Autoclave Protective glasses
Eye wash station
Biosafety cabinet
0
20
40
60
80
100 9488 86
76
18 15 14 11 11
Perc
ent o
f lab
orat
orie
s, %
![Page 54: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/54.jpg)
STAFF TRAINED IN KEY TESTS AND LABORATORY MANGEMENT SKILLS
Quality control
Inventory
Biosafety
AFB
HIV rapid test
Malaria
Hematology
Syphilis
Clinic chemistry
CD4 test
Man
agem
ent s
kills
HIV-
rela
ted
test
ing
0 10 20 30 40 50 60 70 80 90
54
43
35
84
79
77
67
67
65
60
Percent of staff, %
![Page 55: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/55.jpg)
QUALITY ASSURANCE/QUALITY CONTROL FOR HIV RELATED TESTS
HIV rapid test (n=635)
CD4 test (n=175)
Hematology (n=314)
Clinical chemistry test (n=171)
0
20
40
60
80
100100
66
48
70
37
24
14 13
3947
1723
Internal controlInternal proficiencyExternal proficiency
Perc
ent o
f lab
orat
orie
s, %
![Page 56: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/56.jpg)
OUTLINE• Rationale & Objectives• General findings• Capacity score• Summary& Implications
![Page 57: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/57.jpg)
ICAP’S LABORATORY CAPACITY BUILDING FRAMEWORK
Objective Components
1. Improve Integrated Laboratory Infrastructure
physical infrastructure, equipment and accessories
2. Strengthen laboratory personnel capacity
personnel capacity to provide high-quality diagnostic services
3. Improve Laboratory Quality Management System
quality management systems & lab accreditation
4. Strengthen the laboratory network system
laboratory referral system & EQA schemes
![Page 58: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/58.jpg)
LABORATORY CAPACITY SCOREScore Domain Lab PFaCTS Variables
1. Improve Integrated Laboratory Infrastructure
• HIV related tests• laboratory equipment• biosafety equipment/materials• supply chain management system • supply shortages• data collection & specimen
transportation
2. Strengthen laboratory personnel capacity
• % staff received training on each test
3. Improve Laboratory Quality Management System
• SOP, Internal controls, internal and external proficiency testing
Total Points = 100
![Page 59: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/59.jpg)
CAPACITY SCORES BY FACILITY TYPE AND LOCATION
All (n=654)
Primary (n=511)
Secondary (n=126)
Tertiary (n=17)
Urban (n=111)
Semi-urban (n=250)
Rural (n=240)
Unknown (n=53)
0
20
40
60
80
100
48 45
61 5953
4945 44
Aver
age
capa
city
scor
e
![Page 60: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/60.jpg)
CAPACITY SCORES BY COUNTRY AND YEAR
All countries (n=331)
Cote d'Ivoire (n=3)
DR Congo (n=6)
Ethiopia (n=74)
Kenya (n=125)
Mozambique (n=26)
Tanzania (n=97)
0
20
40
60
80
100
46
63
3643 45
37
525156 55 56
5043
5120112013
Aver
age
capa
city
sco
re
*Restricted to laboratories completing both 2011 and 2013 Pfacts rounds.
![Page 61: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/61.jpg)
CAPACITY SCORES BY FACILITY AND LOCATION
*Restricted to laboratories completing both 2011 and 2013 PFaCTs rounds.
Primary (n=212)
Secondary (n=106)
Tertiary lab (n=13)
Urban (n=57)
Semi-urban
(n=113)
Rural (n=132)
Unknown (n=29)
0
20
40
60
80
100
41
5560
4552
4339
45
62 6156 56
47 44 20112013
Aver
age
capa
city
sco
re
![Page 62: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/62.jpg)
OUTLINE• Rationale & Objectives• General findings• Capacity score• Summary& Implications
![Page 63: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/63.jpg)
SUMMARY • ICAP supports a wide range of capacity
building activities in the countries where we work
• Technical support areas identified include QA/QC, human resources and infrastructure
• Capacity at ICAP laboratories– highest at secondary and tertiary and urban
facilities – increased between 2011 and 2013
![Page 64: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/64.jpg)
IMPLICATIONS• Laboratory PFaCTS can be used to
identify and address technical support area needs
• Use of capacity scoring allows for a comprehensive approach to monitoring capacity from routinely collected PFaCTS data
![Page 65: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/65.jpg)
PFACTS DATA USE• Analysis of key PFaCTS variables can
identify areas for targeted technical assistance as well as achievement of program successes
• Innovative approaches in the use of PFaCTS data help us better understand the programs we support
![Page 66: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/66.jpg)
Where’s the Data?
![Page 67: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/67.jpg)
![Page 68: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/68.jpg)
URS
![Page 69: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/69.jpg)
![Page 70: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/70.jpg)
Wiki
![Page 71: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/71.jpg)
![Page 72: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/72.jpg)
Wiki
![Page 73: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/73.jpg)
Acknowledgements
• Country M&E, Laboratory and Clinical Teams
• Bereket Alemayehu, Yingfeng Wu, Suzue Saito, SI Specialists
![Page 74: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/74.jpg)
Thank You
![Page 75: Caitlin Madevu-Matson (cm3315@columbia.edu) Charon Gwynn (crg2128@columbia.edu) SI-NY](https://reader035.vdocuments.mx/reader035/viewer/2022062302/56816426550346895dd5e43e/html5/thumbnails/75.jpg)
FOR MORE INFORMATION
PFaCTS resources• To view the questionnaires and reports for all
rounds, visit the ICAP Data Dissemination page and select PFaCTS.• http://icapdatadissemination.wikischolars.columbia.edu/
Welcome
• To access more PFaCTS results, log into the URS • https://urs2.icap.columbia.edu/